India's Dr Reddy's Recalls U.S. Batches Of Four Oversized Generics
This article was originally published in PharmAsia News
Executive Summary
Dr Reddy's Laboratories of India issued a U.S. recall of some batches of four of its drugs after some of the tablets were found to exceed the permitted size